Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade

Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $5.14, gaining 68.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.50 indicates a 590.7% upside potential.The average comprises six short-term price targets ranging from a low of $3 to a high of $75, with a standard deviation of $23.86. While the lowest estimate indicates a decline of 41.6% from t ...